DIGOXIN
DIGITALIS GLYCOSIDES · CHRONIC HEART FAILURE ·+1
Hikma Pharmaceuticals USA
Drug class
Digitalis Glycosides
Digitalis glycosides, also referred to as cardiac glycosides, are a class of naturally derived cardiovascular agents—most notably digoxin—traditionally extracted from digitalis plants. Read more about Digitalis Glycosides
30 drugs in this class 27 manufacturers
Drugs in Digitalis Glycosides
LANOXIN (digoxin)
DIGITALIS GLYCOSIDES · CHRONIC HEART FAILURE ·+1
ADVANZ PHARMA (
DIGOXIN
DIGITALIS GLYCOSIDES · CHRONIC HEART FAILURE ·+1
REMEDYREPACK, I
Filter & compare in the drug finder →
Opens the drug finder with Digitalis Glycosides preselected. Add indication or manufacturer filters there.
Digitalis glycosides, also referred to as cardiac glycosides, are a class of naturally derived cardiovascular agents—most notably digoxin—traditionally extracted from digitalis plants.
They act primarily by reversibly inhibiting myocardial sodium-potassium adenosine triphosphatase (Na+/K+-ATPase), which increases intracellular calcium to enhance cardiac contractility (positive inotropy) while simultaneously augmenting vagal tone to slow conduction through the atrioventricular node.
Consequently, the class is used in clinical practice for the management of mild-to-moderate heart failure and for ventricular rate control in atrial fibrillation and other atrial tachyarrhythmias.
-
nih.gov
Digitalis glycosides, also referred to as cardiac glycosides, are a class of naturally derived cardiovascular agents—most notably digoxin—traditionally extracted from digitalis plants They act primarily by reversibly inhibiting myocardial sodium-potassium adenosine triphosphatase (Na+/K+-ATPase), which increases intracellular calcium to enhance cardiac contractility (positive inotropy) while simultaneously augmenting vagal tone to slow conduction through the atrioventricular node
-
nih.gov
Digitalis glycosides, also referred to as cardiac glycosides, are a class of naturally derived cardiovascular agents—most notably digoxin—traditionally extracted from digitalis plants
-
nih.gov
They act primarily by reversibly inhibiting myocardial sodium-potassium adenosine triphosphatase (Na+/K+-ATPase), which increases intracellular calcium to enhance cardiac contractility (positive inotropy) while simultaneously augmenting vagal tone to slow conduction through the atrioventricular node Consequently, the class is used in clinical practice for the management of mild-to-moderate heart failure and for ventricular rate control in atrial fibrillation and other atrial tachyarrhythmias
-
nih.gov
Consequently, the class is used in clinical practice for the management of mild-to-moderate heart failure and for ventricular rate control in atrial fibrillation and other atrial tachyarrhythmias
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.